Yao J, Wu H, Wu L, Yu Q, et al. Combined Upadacitinib and Vedolizumab as 8-Week Induction Therapy for Moderate-to-Severe Ulcerative Colitis: A Multicenter, Randomized Controlled Trial. Clin Gastroenterol Hepatol 2026 May 21:S1542-3565(26)00388.
PMID: 42173298